Precigen (PGEN) Share-based Compensation (2012 - 2026)

Precigen's (PGEN) quarterly Share-based Compensation came in at $146000.0 in Q1 2026, down 94.55% year-on-year from $2.7 million in Q1 2025, and down 93.25% on a QoQ basis from $2.2 million in Q4 2025.

Precigen (PGEN) Share-based Compensation (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Share-based Compensation data on file, last reported at $146000.0 in Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 94.55% year-over-year to $146000.0 in Q1 2026; TTM through Mar 2026 was $8.3 million, a 12.88% decrease from a year earlier, with the FY2025 full-year figure at $10.9 million, up 14.73% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $146000.0, down from $2.2 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PGEN reached as high as $6.9 million in Q3 2025 and fell as low as -$7.6 million in Q4 2023.
  • Historically, Share-based Compensation has averaged $1.8 million across 5 years, with a median of $2.3 million in 2023.
  • Across the five-year window, Share-based Compensation sank 445.07% in 2023 and soared 186.47% in 2024, its largest moves.
  • Year by year, Share-based Compensation stood at $2.2 million in 2022, then sank by 445.07% to -$7.6 million in 2023, then jumped by 137.57% to $2.9 million in 2024, then dropped by 24.5% to $2.2 million in 2025, then sank by 93.25% to $146000.0 in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $146000.0 in Q1 2026, $2.2 million in Q4 2025, and $6.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 146,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 146,000.00
Mar 31, 2026 146,000.00
Dec 31, 2025 2.16 Mn
Dec 31, 2025 2.16 Mn
Sep 30, 2025 6.93 Mn
Sep 30, 2025 6.93 Mn
Jun 30, 2025 -901,000.00
Jun 30, 2025 -901,000.00
Mar 31, 2025 2.68 Mn
Mar 31, 2025 2.68 Mn
Dec 31, 2024 2.87 Mn
Dec 31, 2024 2.87 Mn
Sep 30, 2024 6.61 Mn
Sep 30, 2024 6.61 Mn
Jun 30, 2024 -2.58 Mn
Jun 30, 2024 -2.58 Mn
Mar 31, 2024 2.58 Mn
Mar 31, 2024 2.58 Mn
Dec 31, 2023 -7.63 Mn
Dec 31, 2023 -7.63 Mn